Abstract
The growth of Sarcoma 180 cells (S-180), whether dependent on the synthesis of purine nucleotides de novo (folate medium) or on preformed purines (amethopterin medium) such as hypoxanthine, adenine, or adenosine, was inhibityed by 50 and 100% at 15-22 and 100 µM N6-(Δ2-isopentenyl)adenosine, respectively. This adenosine analogue was shown to accumulate in the cell water in the form of the 5'-monophosphate at 2 mM when the extracellular nucleoside level was 100 µM. In S-180 cells incubated with 100 and 300 µM N6-(Δ2-isopentenyl)adenosine and 30 µM [8-14C]adenine the formation of [8-14C]ATP was inhibited by 55 and 64%, respectively, and [8-14C]AMP accumulated at 53 µM as compared with the control, where AMP was undetectable. Under similar conditions the conversion of 100 µM [8-14C]hypoxanthine to ATP and GTP was inhibited by 51 and 65%, respectively. A study was made on the effect of chemically prepared N6-(Δ2-isopentenyl)adenosine 5'-monophosphate on several enzymes involved in the metabolism of purine nucleotides, using cellfree extracts of S-180 cells. This compound inhibited adenosine kinase by competing with ATP (Ki/Km, 1.4), adenine phosphoribosyltransferase by competing with 5-phosphoribosyl 1-pyrophosphate (Ki/Km, 4.0), AMP kinase by competing with AMP (Ki/Km, 8.8), IMP dehydrogenase by competing with IMP (Ki/Km, 15), and adenylosuccinate synthetase noncompetitively with respect to IMP (Ki, 3.0 mM). This nucleotide analogue was also a moderate inhibitor of 5-phosphoribosyl 1-pyrophosphate synthetase, and a poor inhibitor of adenylosuccinate lyase, hypoxanthine phosphoribosyltransferase, and guanylate kinase. Since the multiplication of S-180 cells in vitro is independent of preformed purines, it appears that the inhibition of adenine phosphoribosyltransferase or of adenosine kinase cannot be the basis for the cytotoxicity of N6-(Δ2-isopentenyl)adenosine. The intracellular pools of AMP and IMP were normally quite low (much less than 0.1 mM) as compared with that of N6-(Δ2-isopentenyl)adenosine 5'-monophosphate. It appears, therefore, that AMP kinase and IMP dehydrogenase may be the critical sites of action. Inhibition of these enzymatic steps could cause a shortage of ATP and GTP, leading to inhibition of all the synthetic processes requiring these triphosphates and, eventually, to cell death.
- Copyright ©, 1974, by Academic Press, Inc.
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|